Home Healthcare

Healthcare

Impact focus – Solutions that remimagine access and affordability of healthcare

German start-up BioNTech raised $325 million in private funding, one of the largest hauls for a European biopharma company, which will help it develop its pipeline for cancer therapies designed to target unique characteristics of each patient’s...
Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. Just two drops of blood is all it takes — that is Sight Diagnostics’ promise to analyze, in a matter of seconds,...
KEY TAKEAWAYS Africa’s pharmaceutical distribution market and supply chain are highly fragmented, and drugs are simply not affordable for a large portion of African patients. Distributors and retail margins are also significantly pushing up the price of medications. To...
Life sciences start-up MEND believes better nutrition will help concussion patients before and after surgery, and is seeking to roll out another of its supplement powders to tap that market. The New York company...
Xbiome, which calls itself China’s first AI-based company that specializes in the development of gut microbiome, has raised a total of about $10 million in two venture funding rounds as investors pour money into firms developing products...
KEY TAKEAWAYS Instances of both infectious and chronic diseases are plaguing developing countries in Africa. This health problem presents a healthcare crisis, as spending skyrockets and efficient primary care becomes difficult for people to attain in the region. The disease...
On Our Radar: Deals we are paying attention to for their impact on industry. CMS Medical Venture Investment has bought a quarter of Midatech Pharma Plc’s stock outstanding, reported Bloomberg on April 8. Both are specialty pharmaceutical companies, with CMS owned by...
Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. The web of regulatory and individual privacy requirements in the U.S. makes it extremely difficult to be innovative in the healthcare sector. Even...
On Our Radar: Deals we are paying attention to, for their impact on industry. Surging popularity of home DNA kits that enable consumers to uncover secrets of their ancestry and health risks has fueled speculation that the industry is set...
While Elon Musk’s brain implant company, Neuralink, has announced plans to begin human patient tests before the end of next year, experts believe proving the technology’s competence may take longer. In an event yesterday,...
On Our Radar: Deals we are paying attention to, for their impact on industry Russian scientist Denis Rebrikov told Nature he’s planning the same experiment a Chinese scientist did last year that the rest...
On Our Radar: Deals we are paying attention to for their impact on industry. IA Capital Group, a venture capital firm focused on the new field of insurance-related technology, or insurtech, raised $150 million across three funds. With seven funds and managed...
On Our Radar: Deals we are paying attention to for their impact on industry. Get with it, bro culture. Femtech is thriving and able to generate cash big time. The women’s health company Elvie announced on April 2, that it has raised its...
With chronic care – conditions like diabetes, COPD, cancer, hypertension and others – soaking up ever more healthcare resources, providers and insurers are searching for ways to address preventative and behavioral risks before they grow into...
KEY TAKEAWAYS Millennials are demanding healthcare services that are patient-centric, flexible, adaptive, transparent, and cost-effective, allowing innovators to seize market share from moribund healthcare industry. Global private equity investments in the healthcare sector breached historic highs of $43B in...
KEY TAKEAWAYS Digital pharmacies, with their focus on consumer experience and convenience, are expanding rapidly. Their ability to offer services beyond those of traditional pharmacies, such as medication management and patient engagement, will ultimately determine the success of these...
KEY TAKEAWAYS The rising age of mothers at childbirth, health stressors, and high costs of living are boosting the global need for fertility services. In response to these trends, Private Equity firms are deploying capital to push for industry...
Sound Businesses: Profiles of companies and business models we are keeping an eye on. It’s been an interesting year for Poseida Therapeutics, the human therapeutics company that spun out of Transposagen Biopharmaceuticals in 2015. Poseida in January filed for an...
KEY TAKEAWAYS Millennials are demanding healthcare services that are patient-centric, flexible, adaptive, transparent, and cost-effective, allowing innovators to seize market share from moribund healthcare industry. Global private equity investments in the healthcare sector breached historic highs of $43B in...
KEY TAKEAWAYS The high - and rising - cost of healthcare has prompted the rise of new models of health insurance. Whether new health insurers organize health insurance around new technologies, medical expertise, or cost transparency, their ultimate success...
On Our Radar: Deals we are paying attention to for their impact on industry. Venture capital firm Hatteras Venture Partners raised $94 million for its sixth fund, HVP VI, with plans to hit $200 million for investments in life science...
KEY TAKEAWAYS The high - and rising - cost of healthcare has prompted the rise of new models of health insurance. Whether new health insurers organize health insurance around new technologies, medical expertise, or cost transparency, their ultimate success...
KEY TAKEAWAYS The high - and rising - cost of healthcare has prompted the rise of new models of health insurance. Whether new health insurers organize health insurance around new technologies, medical expertise, or cost transparency, their ultimate success...
Germany’s Vasopharm raised $10.7 million as it plans to submit data for a clinical trial next year for its product that seeks to treat an issue with far-reaching social implications: traumatic brain injury.  Led...
The final chapter in Elizabeth Holmes’ story as an entrepreneur is set to begin next year with her fraud trial scheduled for summer of 2020. But medical device startups and investors may find the fallout from the...
Europe is looking to revolutionize healthcare with a massive project that would  make millions of patient records available to artificial intelligence algorithms. The multi-billion-dollar European Health Data and Evidence Network project will standardize 100...
On Our Radar: Deals we are paying attention to for their impact on industry. Clinical-stage biopharmaceutical company SpringWorks Therapeutics, Inc. moved closer on April 1 to advancing medicines for patients with severe rare diseases and cancer when it closed a $125 million...
Dreamlight Tech is rolling out its new meditation sleep mask in a growing market for relaxation devices funded by private capital, while at the same time fending off criticism of the equipment’s effectiveness over the long run.
While wearable fitness technology -- from Motiv rings to bras that can track cardiovascular disease -- has been gaining popularity, there are consumer segments that haven’t been enamored with the new tech: women and minorities. 
KEY TAKEAWAYS Underfunded African health systems are spurring an influx of private investment into the region. Indian private players, such as Moolchand Healthcare and Fortis Healthcare, are increasingly entering Africa’s $35 billion healthcare market to improve access and costs...
- Advertisement -